Evidence for the aetiological role of blood‐borne virus infections in causing reduced lectin‐induced T‐cell proliferation in haemophilic boys

Summary T‐lymphocyte function, as expressed by polyclonal proliferation to lectin mitogens phytohaemagglutinin and concanavalin A, has been studied in a normal control population and three groups of haemophilic boys: group 1, HIV and HCV seronegative and treated only with a single heat‐treated factor VILT (FVITI) concentrate; group 2, HIV seronegative but HCV seropositive; group 3, all HIV and HCV seropositive. Groups 2 and 3 have been previously treated with unheated and heated FVIII concentrate. Group 1 boys (HIV/HCV uninfected) showed no significant reduction in lymphocyte proliferation when compared with a control population. Group 2 and 3 boys showed an impaired response to these mitogens compared to group 1 boys and the control group. There was no relationship between FVIII concentrate received and proliferative response. The absence of immune modulation in haemophilic boys who have not acquired HIV and HCV infection implicates chronic blood‐borne virus infections as the major contributory factors to impaired lymphocyte proliferative responses seen in haemophiliacs treated with large‐pool concentrates. The presence of virus infections, such as HCV, may account for similar lymphocyte function abnormalities observed in previously described cohorts.

[1]  M. Wadhwa,et al.  Mechanisms of inhibition of T cell IL‐2 secretion by factor VIII concentrates , 1992, British journal of haematology.

[2]  K. Pasi,et al.  Consistently normal CD4+, CD8+ levels in haemophilic boys only treated with a virally safe factor VIII concentrate (BPL 8Y) , 1991, British journal of haematology.

[3]  C. Hay,et al.  Inhibition of lymphocyte IL2‐receptor expression by factor VIII concentrate: a possible cause of immunosuppression in haemophiliacs , 1990, British journal of haematology.

[4]  K. Pasi,et al.  Serological evidence that dry heating of clotting factor concentrates prevents transmission of non‐A, non‐B hepatitis , 1990, Journal of medical virology.

[5]  K. Pasi,et al.  Safety trial of heated factor VIII concentrate (8Y). , 1989, Archives of disease in childhood.

[6]  P. Dilger,et al.  Inhibition of interleuk:in‐2 secretion by factor VIII concentrates: a possible cause of immunosuppression in haemophiliacs , 1989, British journal of haematology.

[7]  R. E. Millard,et al.  Functional studies of cell‐mediated immunity in haemophilia and other bleeding disorders , 1988, British journal of haematology.

[8]  A. Weiss,et al.  Ligand-receptor interactions required for commitment to the activation of the interleukin 2 gene. , 1987, Journal of immunology.

[9]  M. Fritzler,et al.  T Lymphocytes from Hemophiliacs Proliferate after Exposure to Factor VIII Product , 1986, Vox sanguinis.

[10]  M. Lederman,et al.  Antihemophilic factor [factor VIII] preparations inhibit lymphocyte proliferation and production of interleukin-2. , 1986, The Journal of laboratory and clinical medicine.

[11]  R. Newcombe,et al.  A study of cell mediated and humoral immunity in haemophilia and related disorders , 1985, British journal of haematology.

[12]  R. Prescott,et al.  ABNORMALITIES OF CIRCULATING LYMPHOCYTE SUBSETS IN HAEMOPHILIACS IN AN AIDS-FREE POPULATION , 1984, The Lancet.

[13]  P. Nowell Phytohemagglutinin: an initiator of mitosis in cultures of normal human leukocytes. , 1960, Cancer research.

[14]  F. Ruymann,et al.  HTLV-III status and abnormalities in T lymphocyte distribution in children with hemophilia A. , 1986, Diagnostic immunology.

[15]  M. Crumpton,et al.  The mitogenic lectin from Phaseolus vulgaris does not recognize the T3 antigen of human T lymphocytes , 1985, European journal of immunology.

[16]  N. Sharon,et al.  Lectin receptors as lymphocyte surface markers. , 1983, Advances in immunology.